Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 283,989 | 278,633 | 264,566 | 244,317 | 259,602 |
| Cost of Goods | 26,225 | 21,647 | 20,734 | 20,392 | 21,803 |
| Gross Profit | 257,764 | 256,986 | 243,832 | 223,925 | 237,799 |
| Operating Expenses | 240,598 | 221,877 | 212,192 | 205,027 | 85,099 |
| Operating Income | 17,391 | 35,756 | 32,374 | 19,290 | 153,503 |
| Other Income | 8,928 | 8,839 | 7,837 | 8,489 | 7,582 |
| Pre-tax Income | 26,319 | 44,595 | 40,211 | 27,779 | 161,085 |
| Income Tax | -247,249 | -27,184 | 13,545 | 8,792 | 17,343 |
| Net Income Continuous | 273,568 | 71,779 | 26,666 | 18,987 | 143,742 |
| Net Income | $273,568 | $71,779 | $26,666 | $18,987 | $143,742 |
| EPS Basic Total Ops | 1.62 | 0.43 | 0.16 | 0.11 | 0.87 |
| EPS Basic Continuous Ops | 1.62 | 0.43 | 0.16 | 0.11 | 0.87 |
| EPS Diluted Total Ops | 1.61 | 0.42 | 0.16 | 0.11 | 0.86 |
| EPS Diluted Continuous Ops | 1.61 | 0.42 | 0.16 | 0.11 | 0.86 |
| EPS Diluted Before Non-Recurring Items | 0.16 | 0.26 | 0.16 | 0.11 | 0.17 |
| EBITDA(a) | $19,645 | $37,604 | $33,773 | $20,125 | $155,900 |